Novo Nordisk enters into collaboration with Danish crispr firm Snipr

The small Danish biotech company Snipr Biome, which uses crispr technology, has landed its first partnership.
Photo: Novo Nordisk / PR
Photo: Novo Nordisk / PR
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

Shortly after Snipr Biome managed to bring in new money through its first non-commercial partnership with antimicrobial alliance Carb-X, the Danish company has now managed to find its first commercial partner.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading